Noubar Afeyan

Noubar Afeyan

American entrepreneur, venture capitalist, inventor, technologist, and CEO.

All edits

Edits on 6 Mar, 2021
Chirag Jain
Chirag Jain edited on 6 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founder of
Seres Therapeutics
Chirag Jain
Chirag Jain edited on 6 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founder of
Seres Health
Edits on 3 Mar, 2021
Golden AI
Golden AI edited on 3 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founder of
Ring Therapeutics
Edits on 3 Mar, 2021
Amit Gehlot
Amit Gehlot edited on 3 Mar, 2021
Edits made to:
Infobox (-1 properties)
Infobox
CEO of
Rubius Therapeutics
Edits on 1 Mar, 2021
Amit Gehlot
Amit Gehlot edited on 1 Mar, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Founder of
Cogen Therapeutics
Edits on 13 Feb, 2021
Neelam Jhaveri
Neelam Jhaveri edited on 13 Feb, 2021
Edits made to:
Infobox (+2 properties)
Infobox
CEO of
Rubius Therapeutics
Founder of
Rubius Therapeutics
Edits on 13 Jan, 2021
Golden AI"Infobox creation from: Wikidata data enrichment"
Golden AI approved a suggestion from Golden's AI on 13 Jan, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Educated at
Massachusetts Institute of Technology
Golden AI
Golden AI edited on 13 Jan, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Subsidiary
Moderna Therapeutics
Edits on 17 Dec, 2020
Amy Tomlinson Gayle
Amy Tomlinson Gayle edited on 17 Dec, 2020
Edits made to:
Article (+3/-4 characters)
Article

In 2000, Afeyan founded Flagship Ventures (renamed Flagship Pioneering in 2016), where he currently serves as Senior Managing Partner and CEO. Flagship Pioneering focuses on creating and investing in first-in-category, high-value life science companies in three principal business sectors: therapeutics, health technologies, and sustainability. The company creates companies through a systemic model of entrepreneurial science. Flagship's team of scientists poses scientific hypotheses, works to finesse them, and conducts proof-of-concept experiments that eventually leadled to new scientific IP and companies with disruptive potential. Since 2000 this process has led to the launch of around 40 companies. The firm also works with external academic innovations and, in some cases, with early-stage companies looking to partner.

Edits on 6 Dec, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 6 Dec, 2020
Edits made to:
Article (+4/-4 characters)
Article

In 2007, Afeyan and David Berry (inventor) co-founded Joule Unlimited, which is developing Solar Fuels—drop-in fuels produced directly from the sun. In March 2010 and in March 2011, Joule was named by Technology Review as one of the 50 Most Innovative Companies. Joule was named as one of the 10 most important emerging technologies in 2010. Joule's unique and innovative approach to fuels led to its being named a Technology Pioneer by the World Economic Forum in 2012 and to its receiving the Silver Medal in the 2011 Wall Street Journal Technology Innovation Awards. Joule's technology has been scaled to a demonstration facility, and the company has announced a commercial partnership with AudiAudi. Afeyan cofounded Moderna Therapeutics with Kenneth Chien of Harvard University and the Karolinka Institutet, Robert Langer of the Massachusetts Institute of Technology, and Derrick Rossi of Boston Children’s Hospital. The company launched from Flagship Pioneering’s innovation foundry, VentureLabs, in 2010. Since launch, Moderna has raised venture funding in excess of $1B.

Edits on 4 Dec, 2020
Erin Scherfner
Erin Scherfner edited on 4 Dec, 2020
Edits made to:
Infobox (+2 properties)
Timeline (+1 events) (+375 characters)
Further reading (+6 rows) (+27 cells) (+1137 characters)
Documentaries, videos and podcasts (+3 rows) (+13 cells) (+558 characters)
Further reading

Title
Author
Link
Type
Date

Armenian President phones Moderna's Noubar Afeyan over coronavirus vaccine

Web

March 21, 2020

How the biotech investor behind Moderna is using the 'immigrant mindset' to take on COVID-19

Erika Fry

Web

May 19, 2020

Immigrant-Founded Moderna Leading The Way In Covid-19 Response

Stuart Anderson

Web

August 11, 2020

In His Spare Time, Immigrant Noubar Afeyan Has Started 38 Companies In America

Stuart Anderson

Web

March 19, 2016

Noubar Afeyan - a life story worth reading

Web

What we know about Moderna's COVID-19 vaccine candidate -- and what we don't

Judy Woodruff

Web

November 16, 2020

Documentaries, videos and podcasts

Title
Date
Link

Dr Noubar Afeyan

October 21, 2019

Dr. Noubar Afeyan talks about Moderna's COVID-19 vaccine at webinar held by Armenian organizations

March 29, 2020

Moderna chairman: We don't need deep-freeze conditions for vaccine - CNN Video

November 16, 2020

Infobox
Nationality
United States
Timeline

November 12, 2020

Moderna's Dr. Noubar Afeyan to Speak at IEEE InTech Forum on Tech Industry's Response to Covid-19.

Dr. Noubar Afeyan, Flagship Pioneering's founder and CEO and Moderna chairman, will be a keynote speaker at IEEE InTech Forum, taking place virtually on 2-3 December 2020. Dr. Afeyan will be speaking on the topic, "Moderna, Pandemic Vaccines, and the Path to Health Security."

Erin Scherfner
Erin Scherfner edited on 4 Dec, 2020
Edits made to:
Infobox (+7 properties)
Article (+17/-13 characters)
Article

Noubar Afeyan (born July 25, 1962), is an American entrepreneur, venture capitalist, inventor, technologist, and CEO. In 2000, Afeyan founded Flagship Pioneering to create and fund early-stage start-ups addressing unmet needs in healthcare and sustainability. He is a Senior Lecturer at the MIT Sloan School of Management. He lectures in the United States and internationally on topics ranging from entrepreneurship, innovation, and venture capital to biological engineering, drug discovery, medical technologies, and renewable energy.

...

In 1988, Afeyan founded PerSeptive Biosystems in Cambridge, MA. While CEO of PerSeptive, Afeyan co-founded and funded numerous other biotechnology companies, including: ChemGenics Pharmaceuticals, acquired by Millennium Pharmaceuticals in 1997; Exact Sciences (NASDAQ:EXAS), Agenus (NASDAQ:AGEN); and Color Kinetics, acquired by Philips 2007. After PerSeptive's acquisition by Perkin Elmer/Applera Corporation in 1998, he became Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics.

...

In 2000, Afeyan founded Flagship Ventures (renamed Flagship Pioneering in 2016), where he currently serves as Senior Managing Partner and CEO. Flagship Pioneering focuses on creating and investing in first-in-category, high-value life science companies in three principal business sectors: therapeutics, health technologies, and sustainability. The company creates companies through a systemic model of entrepreneurial science. Flagship's team of scientists poses scientific hypotheses, works to finesse them, and conducts proof-of-concept experiments that eventually lead to new scientific IP and companies with disruptive potential. Since 2000 this process has led to the launch of around 40 companies. The firm also works with external academic innovations and, in some cases, with early-stage companies looking to partner.

...

In 2007, Afeyan and David Berry (inventor) co-founded Joule Unlimited, which is developing Solar Fuels—drop-in fuels produced directly from the sun. In March 2010 and in March 2011, Joule was named by Technology Review as one of the 50 Most Innovative Companies. Joule was named as one of the 10 most important emerging technologies in 2010. Joule's unique and innovative approach to fuels led to its being named a Technology Pioneer by the World Economic Forum in 2012 and to its receiving the Silver Medal in the 2011 Wall Street Journal Technology Innovation Awards. Joule's technology has been scaled to a demonstration facility, and the company has announced a commercial partnership with Audi.AfeyanAudi. Afeyan cofounded Moderna Therapeutics with Kenneth Chien of Harvard University and the Karolinka Institutet, Robert Langer of the Massachusetts Institute of Technology, and Derrick Rossi of Boston Children’s Hospital. The company launched from Flagship Pioneering’s innovation foundry, VentureLabs, in 2010. Since launch, Moderna has raised venture funding in excess of $1B.

...

Since 2000, Afeyan has been teaching courses on entrepreneurship, innovation, and leadership at the Massachusetts Institute of Technology’s Sloan School of Management. From 2007 to 2010, he also served on Boston University’s Board of Overseers. Afeyan has authored numerous scientific publications and patents.

...

Afeyan is Chairman of the Global Agenda Council on Emerging Technologies of the World Economic Forum. He is also co-founder and board member of the National Competitiveness Foundation of Armenia, a private-public partnership to promote economic development in the former Soviet Republic of Armenia. He serves on the board of Ameriabank, a leading bank in Armenia. Afeyan serves on multiple charitable and corporate boards, including those of Codiak Biosciences, Evelo Biosciences, Joule Unlimited, and Axcella. Since 2008, he has served on the Boston Symphony Orchestra’s Board of Overseers. He is also on the board of the MIT Corporation.

...

Afeyan’s awards include the Ellis Island Medal of Honor, an award granted to outstanding Americans who have distinguished themselves as U.S. citizens, and who exemplify outstanding qualities in both their personal and professional lives, while continuing to preserve the richness of their particular heritage. Afeyan also received a Technology Pioneer 2012 award from the World Economic Forum in recognition of the breakthrough solar fuel technology being developed at Joule Unlimited.

Infobox
CEO of
Flagship Pioneering
Current Employer
Massachusetts Institute of Technology
Known for
Founding Flagship Pioneering and Moderna Therapeutics
Location
Cambridge, Massachusetts
Edits on 24 Nov, 2020
Charlie Hilton
Charlie Hilton edited on 24 Nov, 2020
Edits made to:
Related Topics (+1 topics)
Related Topics
Charlie Hilton
Charlie Hilton edited on 24 Nov, 2020
Edits made to:
Topic thumbnail

Noubar Afeyan

American entrepreneur, venture capitalist, inventor, technologist, and CEO.

Edits on 28 Jul, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 28 Jul, 2020
Edits made to:
Article (+14/-14 characters)
Article

In 1988, Afeyan founded PerSeptive Biosystems in Cambridge, MA. While CEO of PerSeptive, Afeyan co-founded and funded numerous other biotechnology companies, including: ChemGenics Pharmaceuticals, acquired by Millennium Pharmaceuticals in 1997; Exact Sciences (NASDAQ:EXAS), Agenus (NASDAQ:AGEN); and Color KineticsColor Kinetics, acquired by Philips 2007. After PerSeptive's acquisition by Perkin Elmer/Applera Corporation in 1998, he became Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics.

Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 27 Jul, 2020
Edits made to:
Article (+18/-18 characters)
Article

In 2007, Afeyan and David Berry (inventor) co-founded Joule Unlimited, which is developing Solar Fuels—drop-in fuels produced directly from the sun. In March 2010 and in March 2011, Joule was named by Technology Review as one of the 50 Most Innovative Companies. Joule was named as one of the 10 most important emerging technologies in 2010. Joule's unique and innovative approach to fuels led to its being named a Technology Pioneer by the World Economic Forum in 2012 and to its receiving the Silver Medal in the 2011 Wall Street Journal Technology Innovation Awards. Joule's technology has been scaled to a demonstration facility, and the company has announced a commercial partnership with Audi.Afeyan cofounded Moderna Therapeutics with Kenneth Chien of Harvard UniversityHarvard University and the Karolinka Institutet, Robert Langer of the Massachusetts Institute of Technology, and Derrick Rossi of Boston Children’s Hospital. The company launched from Flagship Pioneering’s innovation foundry, VentureLabs, in 2010. Since launch, Moderna has raised venture funding in excess of $1B.

Edits on 27 Jul, 2020
Golden AI
Golden AI edited on 27 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Founder of
Moderna Therapeutics
Edits on 1 Apr, 2020
Charlie Hilton
Charlie Hilton edited on 1 Apr, 2020
Edits made to:
Description (+3/-3 characters)
Topic thumbnail

Noubar Afeyan

American entrepreneur, venture capitalist, inventor, technologist, and ceoCEO.

Edits on 27 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 27 Feb, 2020
Edits made to:
Article (+14/-14 characters)
Article

Through his work as an entrepreneur both before and at Flagship Pioneering, Afeyan has founded or helped start numerous companies, including Affinnova, Adnexus (acquired by Bristol Myers Squibb), BG Medicine, BIND Therapeutics, Celexion, Eleven Biotherapeutics, Ensemble Therapeutics, Joule Unlimited, LS9, Midori, Moderna Therapeutics, Permeon Biologics, Pronutria Biosciences (later renamed Axcella HealthAxcella Health) and Seres Therapeutics.

Edits on 19 Jan, 2020
Golden AI"Attach Wikidata entity ID"
Golden AI edited on 19 Jan, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Wikidata entity ID
Q14949405
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.